The End Tuberculosis Now Act of 2026 is designed to strengthen global efforts to combat tuberculosis (TB), a significant public health threat. The legislation aims to enhance prevention, treatment, and control measures for TB, with a focus on addressing drug-resistant forms of the disease. Its key objectives include reducing TB incidence and mortality rates significantly by 2030, ensuring high rates of diagnosis and treatment for both drug-sensitive and drug-resistant TB, and providing preventive treatment to millions of individuals.